Pimm – Partial immortalization

A Biotech Geek (micro)Blogger’s adventures through science, technology and the web…

  • email me

    [attilacsordas][at][gmail.com]
  • Attila on Twitter

    Error: Twitter did not respond. Please wait a few minutes and refresh this page.

  • Recent Comments

    HomeAndBodyEssence on Rumors on Amatokin: a skin ste…
    Uk Bingo Bonuses on The marketing problem of life …
    One way back link on Whatbox, Upper Lost Side, Stem…
    revathi on Human mitochondrial DNA vs. nu…
    Bryan- Logo Design on How to read PDF files on iPhon…
    GB on Visualize 23andMe haplogroup d…
    MaryHollmy on Google Health, IBM: real-time,…
    colon hydrotherapy l… on Why the Dyna-Vision G1 Android…
    revathi on Human mitochondrial DNA vs. nu…
    Erik Cole on Michael Rose, evolutionary SEN…
  • licence

    Creative Commons License
  • c

  •  

    January 2008
    M T W T F S S
    « Dec   Feb »
     123456
    78910111213
    14151617181920
    21222324252627
    28293031  

Xoogler goes biotech

Posted by attilachordash on January 23, 2008

I found this quote in John Battelle’s blog from a recent CNET article on ex-Googlers by Stephanie Olsen, but I’d like to repeat it just with a different emphasis as I found all the other parts interesting for the biotech community except the one sentence bolded by Battelle. So I bolded those parts:

Like some of his peers, Harik is investing in small companies like Wi-Fi company Meraki, and he’s helping to develop a Web-based video conferencing company called Imo.im with his brother. Harkening back to his college studies of mathematical models of genetic algorithms, he’s also opening a yet-to-be-named research lab in Palo Alto to develop artificial-intelligence software for the fields of biotech and medicine. He plans to invest about $100,000 in the lab this year.

“The largest intelligence system at Google is in AdSense and the Gmail spam system, but I’ve always really wanted to see our work applied to medicine and biology, which is sort of hard to do at a company,” said Harik, adding that the software will be open-source with access to the entire medical community. The nonprofit is partially funded by Google, Harik said.

Update: Comment on the Searchblog by JG:

Attila: No, even with that different angle, I think the main point remains the same. If you read between the lines, and put your emphasis there, you’ll see a glaring omission: “Search” is not one of the largest two intelligence systems at Google.
Who would have thought that the intelligence system behind Gmail spam filtering is larger than the intelligence system behind search? I would have thought that it is the other way around. That is the big fact, here.

3 Responses to “Xoogler goes biotech”

  1. Deepak said

    I am very curious about this one too. In my experience, many computer scientists apply very interesting and elegant methods to life science problems, but often, they tend to be either impractical or lose a lot of biological context. Will be watching carefully. Let me know if you can dig up any additional dirt.

  2. Jim H said

    Bio-IT is an emerging trend. I have yet to realize it as a significant tool, other than controlling some of my instruments and manipulation and viewing of data. Some of the predictive toxicology modeling is neat, but yet to hold muster to in vivo or in vitro testing.

    Maybe Google can break the mold. I am curious how progress on the uploading of the science libraries from Harvard, Stanford, Michigan, Oxford and Princeton is going since starting in 2004?

  3. [...] biotechnology, google, medicine, technology. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own [...]

Leave a Reply

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <pre> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>